pharma is the sole category represented across all 1 tracked stories. Invesco QQQ is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Intel appears in 1 tracked Biotech story from August 19, 2026. The tracked stories average 2 original sources each.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Intel
pharma is the sole category represented across all 1 tracked stories. Invesco QQQ is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Intel appears in 1 tracked Biotech story from August 19, 2026. The tracked stories average 2 original sources each.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 4 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Intel. Shared-story counts are live from our verified record — not editorial picks.
Moderna appears on both MarketBeat's value and large-cap high-volume screens on August 19, underscoring unusual liquidity and renewed biotech interest despite a post-COVID valuation reset. The mRNA pipeline spans respiratory, latent, and public health vaccines, setting up multiple clinical catalysts.